Marcum Wealth’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,411
Closed -$270K 400
2023
Q2
$270K Sell
6,411
-69
-1% -$2.79K 0.03% 268
2023
Q1
$231K Sell
6,480
-88
-1% -$3.19K 0.03% 295
2022
Q4
$241K Sell
6,568
-176
-3% -$6.96K 0.03% 277
2022
Q3
$318K Sell
6,744
-4
-0.1% -$258 0.05% 230
2022
Q2
$484K Hold
6,748
0.07% 160
2022
Q1
$546K Sell
6,748
-83
-1% -$7.02K 0.08% 149
2021
Q4
$701K Sell
6,831
-1
-0% -$96 0.1% 134
2021
Q3
$598K Buy
+6,832
New +$618K 0.09% 135

Other funds holding SYNH

Marcum Wealth's SYNH Position: Q3 2023 in Review

Marcum Wealth sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 6,411 shares — an estimated $270K sold.

Marcum Wealth first reported a position in SYNH in Q3 2021 and held it in 8 quarters. The position peaked at $701K in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Marcum Wealth reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Marcum Wealth sold 6,411 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $270K.
  • Marcum Wealth first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 8 quarters.
  • Marcum Wealth's Syneos Health, Inc. Class A Common Stock position peaked at $701K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Marcum Wealth's 13F filing for Q3 2023, filed 10 Oct 2023.